MYRIAD GENETICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
MYRIAD GENETICS, INC. (MYGN) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $31.40 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-24
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $31.40M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $37.40M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $45.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $42.80M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $31.40M 10-K · filed 2026-02-24 |
| 2024-12-31 | $37.40M 10-K · filed 2025-02-28 |
| 2023-12-31 | $45.00M 10-K · filed 2024-02-28 |
| 2022-12-31 | $42.80M 10-K · filed 2023-03-01 |
| 2021-12-31 | $40.80M 10-K · filed 2022-02-25 |
| 2020-12-31 | $58.30M 10-KT · filed 2021-03-16 |
| 2020-06-30 | $51.90M 10-K · filed 2020-08-13 |
| 2019-06-30 | $52.00M 10-K · filed 2019-08-13 |
| 2018-06-30 | $37.20M 10-K · filed 2018-08-24 |
| 2017-06-30 | $37.20M 10-K · filed 2017-08-09 |
| 2016-06-30 | $14.20M 10-K · filed 2016-08-10 |
| 2015-06-30 | $12.50M 10-K · filed 2015-08-12 |
| 2014-06-30 | $11.90M 10-K · filed 2014-08-13 |
| 2013-06-30 | $978.00K 10-K · filed 2013-08-14 |
| 2012-06-30 | $967.00K 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |